Figures & data
Table 1. General characteristics of the population of patients with COVID-19 in the studies.
Table 2. General characteristics of the patients discriminated by group of steroids and control.
Table 3. Frequency distribution of comorbidities reported in patients with COVID-19.
Table 4. Mortality discriminated by steroid use and control group.
Figure 2. Confidence intervals evaluated through meta-analysis.
![Figure 2. Confidence intervals evaluated through meta-analysis.](/cms/asset/a2c073d7-ad1e-47b3-9a77-6c61071042f8/ziee_a_2277000_f0002_oc.jpg)
Figure 3. Analysis of publication bias using funnel-plot generated by OR.
![Figure 3. Analysis of publication bias using funnel-plot generated by OR.](/cms/asset/8aadf8bb-282a-4b33-b654-4a2c6c223822/ziee_a_2277000_f0003_oc.jpg)
Table 5. Frequency of superinfection discriminated by steroid use and control group.
Table 6. Meta-analysis of steroid use and risk of superinfection.